| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.45 | 0.007 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |